All,
Firstly, FIGS is THE hot commodity in the healthcare sector. All major doctors, dentists, surgeons love and buy only FIGS no joke. They are a high quality brand and actually a decent company. FIGS looks ready to pop on confluence support here and wedge. We will see, keep an eye out. See financials below, but I would consider them undervalued here by about $5-$10. I could see FIGS at some point in time being near $100 stock if they keep up their revenue and hype with healthcare workers.
Entry #1: now 5% stop
Entry #2: break of wedge w/ trailing stop
Entry #3: wait for wedge break and see what happens on previous channel retest fail (late entry on break 40-41$ vs now.
Could also of couse go down so do your DD
Financials (Almost all good)
**High ROE: FIGS's Return on Equity (49.9%) is considered outstanding.
PE--
PE vs Industry: FIGS is good value based on its PE Ratio (11x) compared to the US Medical Equipment industry average (48.9x).
PE vs Market: FIGS is good value based on its PE Ratio (11x) compared to the US market (17.9x).
ER/Revenue--
Earnings vs Savings Rate: FIGS's forecast earnings growth (40.2% per year) is above the savings rate (2%).
Earnings vs Market: FIGS's earnings (40.2% per year) are forecast to grow faster than the US market (15% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FIGS's revenue (27.6% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: FIGS's revenue (27.6% per year) is forecast to grow faster than 20% per year.
Debt--
Short Term Liabilities: FIGS's short term assets ($146.3M) exceed its short term liabilities ($43.4M).
Long Term Liabilities: FIGS's short term assets ($146.3M) exceed its long term liabilities ($3.6M).
Firstly, FIGS is THE hot commodity in the healthcare sector. All major doctors, dentists, surgeons love and buy only FIGS no joke. They are a high quality brand and actually a decent company. FIGS looks ready to pop on confluence support here and wedge. We will see, keep an eye out. See financials below, but I would consider them undervalued here by about $5-$10. I could see FIGS at some point in time being near $100 stock if they keep up their revenue and hype with healthcare workers.
Entry #1: now 5% stop
Entry #2: break of wedge w/ trailing stop
Entry #3: wait for wedge break and see what happens on previous channel retest fail (late entry on break 40-41$ vs now.
Could also of couse go down so do your DD
Financials (Almost all good)
**High ROE: FIGS's Return on Equity (49.9%) is considered outstanding.
PE--
PE vs Industry: FIGS is good value based on its PE Ratio (11x) compared to the US Medical Equipment industry average (48.9x).
PE vs Market: FIGS is good value based on its PE Ratio (11x) compared to the US market (17.9x).
ER/Revenue--
Earnings vs Savings Rate: FIGS's forecast earnings growth (40.2% per year) is above the savings rate (2%).
Earnings vs Market: FIGS's earnings (40.2% per year) are forecast to grow faster than the US market (15% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FIGS's revenue (27.6% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: FIGS's revenue (27.6% per year) is forecast to grow faster than 20% per year.
Debt--
Short Term Liabilities: FIGS's short term assets ($146.3M) exceed its short term liabilities ($43.4M).
Long Term Liabilities: FIGS's short term assets ($146.3M) exceed its long term liabilities ($3.6M).